• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Factoring in Safety Considerations With IV Iron Products

Opinion
Video

Panelists discuss how black box warnings on IV iron products, particularly regarding hypersensitivity reactions, influence their risk assessment, patient selection, monitoring protocols, and facility requirements for administration, while emphasizing that modern formulations have significantly improved safety profiles compared with older products.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
Barry Byrne, MD
Giulio Cossu, MD
Dr Toon Van Gorp
5 experts are featured in this series
5 experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.